Identification of Hemopexin as an Anti-Inflammatory Factor That Inhibits Synergy of Hemoglobin with HMGB1 in Sterile and Infectious Inflammation
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Hemoglobin is released from lysed RBCs in numerous clinical settings. High mobility group box 1 (HMGB1) is a nuclear and cytosolic DNA-binding protein released from injured cells that has been shown to play an important role in inducing inflammation. Because both of these endogenous molecules are frequently present in sites of necrosis and inflammation, we studied their interaction on the activation of macrophages. We report in this article that hemoglobin and HMGB1 synergize to activate mouse macrophages to release significantly increased proinflammatory cytokines. Addition of microbial ligands that activate through TLR2 or TLR4 resulted in further significant increases, in a “three-way” synergy between endogenous and microbial ligands. The synergy was strongly suppressed by hemopexin (Hx), an endogenous heme-binding plasma protein. The findings suggest that hemoglobin may play an important role in sterile and infectious inflammation, and that endogenous Hx can modulate this response. Administration of Hx may be beneficial in clinical settings characterized by elevated extracellular hemoglobin and HMGB1.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care
Hébert, P. C., Wells, G., Blajchman, M. A., Marshall, J., Martin, C., Pagliarello, G., Tweeddale, M., Schweitzer, I., & Yetisir, E. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400601 · Cited by 5,187
HMGB1 is a therapeutic target for sterile inflammation and infection
Andersson, U., & Tracey, K. J. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101323 · Cited by 1,437 · cited 3×
“There is extensive literature on the role of HMGB1 in promoting inflammation in tissues in which degrading blood cells would be present (11).”
BackgroundSelf-citationA Central Role for Free Heme in the Pathogenesis of Severe Sepsis
Larsen, R., Gozzelino, R., Jeney, V., Tokaji, L., Bozza, F. A., Japiassú, A. M., Bonaparte, D., Cavalcante, M. M., Chora, Â., Ferreira, A., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001118 · Cited by 483 · cited 3×
“However, isolated activation by any single TLR agonist ligand is unlikely to occur in nature (24), and synergy between hemoglobin, HMGB1, and microbial ligands is likely important in sepsis syndrome (7, 14, 25).”
BackgroundHemopexin: structure, function, and regulation
Tolosano, E., & Altruda, F. (2002) · DNA and Cell Biology · doi:10.1089/104454902753759717 · Cited by 426
Kaca, W., Roth, R. I., & Levin, J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31501-6 · Cited by 137
Hemopexin down-regulates LPS-induced proinflammatory cytokines from macrophages
Liang, X., Lin, T., Sun, G., Beasley-Topliffe, L., Cavaillon, J.-M., & Warren, H. S. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.1208742 · Cited by 106 · cited 3×
“Mouse or human serum Hx was purified by using heme affinity chromatography essentially as we have described previously (16).”
BackgroundMethodSelf-citationFernandez, P. L., Dutra, F. F., Alves, L., Figueiredo, R. T., Mourão-Sa, D., Fortes, G. B., Bergstrand, S., Lönn, D., Cevallos, R. R., Pereira, R. M. S., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.146076 · Cited by 95 · cited 9×
“Abbreviations used in this article: BMDM, bone marrow-derived macrophage; DPI, diphenyleneiodonium; HMGB1, high mobility group box 1; Hx, hemopexin; KO, knockout; NAC, N-acetyl-L-cysteine; RAGE, receptor for advanced glycation end products; ROS, reactive oxygen species; Syk, spleen tyrosine kinase; TRIF, Toll/IL-1R do…”
BackgroundInfluentialLin, T., Kwak, Y. H., Sammy, F., He, P., Thundivalappil, S., Sun, G., Chao, W., & Warren, H. S. (2010) · The Journal of Infectious Diseases · doi:10.1086/654929 · Cited by 91 · cited 3×
“During the course of studying the influence of hemoglobin and free heme on macrophage responses to LPS, we recently observed that these molecules also synergistically enhance the macrophage response to TLR4-independent ligands of microbial origin, and to killed Escherichia coli and Staphylococcus aureus (8).”
BackgroundSelf-citation
Cited by
Yang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,253
Kang, R., Chen, R., Zhang, Q., Hou, W., Wu, S., Cao, L., Huang, J., Yu, Y., Fan, X.-G., Yan, Z., et al. (2014) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.05.001 · Cited by 956
Schaer, D. J., Buehler, P. W., Alayash, A. I., Belcher, J. D., & Vercellotti, G. M. (2013) · Blood · doi:10.1182/blood-2012-11-451229 · Cited by 754
Hepatocytes: a key cell type for innate immunity
Zhou, Z., Xu, M.-J., & Gao, B. (2016) · Cellular & Molecular Immunology · doi:10.1038/cmi.2015.97 · Cited by 472
The Compensatory Immune-Regulatory Reflex System (CIRS) in Depression and Bipolar Disorder
Maes, M., & Carvalho, A. F. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1016-x · Cited by 306
Metadata
- Authors
- Lin, T., Sammy, F., Yang, H., Thundivalappil, S., Hellman, J., Tracey, K. J., & Warren, H. S.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-08
- Volume
- 189
- Issue
- 4
- Pages
- 2017-2022
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2125361730
- Cited by
- 86
- References
- 8
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.